* Q4 loss per share $0.28 Source text for Eikon: (1.usa.gov/1XNRIXW) Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

The post BRIEF-Aclaris Therapeutics posts Q4 loss $0.28/share appeared first on NASDAQ.